NetTargets has been selected as one of the top 10 drug discovery startups worldwide, receiving an Honorable Mention in the AI Discovery Award 2025 by Nebius AI.
About Nebius
Nebius is a technology company building full-stack infrastructure to service explosive growth of the global AI industry, including large-scale GPU clusters, cloud platforms, and tools and services for AI developers. Headquartered in Amsterdam and listed on Nasdaq, the company has a global footprint with R&D hubs and offices across Europe, North America and Israel.
Nebius’ core business is an AI-centric cloud platform built for intensive AI/ML workloads. With proprietary cloud software architecture and hardware designed in-house (including servers, racks and data centre design), Nebius provides AI and ML practitioners the compute, storage, managed services and tools they need to build, tune and run their models.
About AI Discovery Award
AI Discovery by Nebius is an annual award for startups that are leveraging AI to revolutionize drug discovery, biotechnology, genomics and healthtech.
Its mission is to spotlight new technologies, foster collaboration between startups and potential investors and propel the next generation of breakthroughs in healthcare.
